BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18687347)

  • 1. A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism.
    Moustafa AA; Sherman SJ; Frank MJ
    Neuropsychologia; 2008 Nov; 46(13):3144-56. PubMed ID: 18687347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
    Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
    Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism.
    Frank MJ
    J Cogn Neurosci; 2005 Jan; 17(1):51-72. PubMed ID: 15701239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neurocomputational model of dopamine and prefrontal-striatal interactions during multicue category learning by Parkinson patients.
    Moustafa AA; Gluck MA
    J Cogn Neurosci; 2011 Jan; 23(1):151-67. PubMed ID: 20044893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.
    Costa A; Peppe A; Dell'Agnello G; Caltagirone C; Carlesimo GA
    Neuropsychologia; 2009 Apr; 47(5):1374-81. PubMed ID: 19428401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
    Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
    Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of internal clock and memory disorders on duration reproductions and duration productions in patients with Parkinson's disease.
    Perbal S; Deweer B; Pillon B; Vidailhet M; Dubois B; Pouthas V
    Brain Cogn; 2005 Jun; 58(1):35-48. PubMed ID: 15878725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
    Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
    Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder.
    Frank MJ; Santamaria A; O'Reilly RC; Willcutt E
    Neuropsychopharmacology; 2007 Jul; 32(7):1583-99. PubMed ID: 17164816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dopaminergic medications on the time course of explicit motor sequence learning in Parkinson's disease.
    Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
    J Neurophysiol; 2010 Feb; 103(2):942-9. PubMed ID: 20018839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease.
    Fern-Pollak L; Whone AL; Brooks DJ; Mehta MA
    Neuropsychologia; 2004; 42(14):1917-26. PubMed ID: 15381022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of the prefrontal cortex and basal ganglia to set shifting.
    Ravizza SM; Ciranni MA
    J Cogn Neurosci; 2002 Apr; 14(3):472-83. PubMed ID: 11970806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feedback-based versus observational classification learning in healthy aging and Parkinson's disease.
    Schmitt-Eliassen J; Ferstl R; Wiesner C; Deuschl G; Witt K
    Brain Res; 2007 Apr; 1142():178-88. PubMed ID: 17300759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocomputational models of motor and cognitive deficits in Parkinson's disease.
    Wiecki TV; Frank MJ
    Prog Brain Res; 2010; 183():275-97. PubMed ID: 20696325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive sequence learning in Parkinson's disease and amnestic mild cognitive impairment: Dissociation between sequential and non-sequential learning of associations.
    Nagy H; Kéri S; Myers CE; Benedek G; Shohamy D; Gluck MA
    Neuropsychologia; 2007 Apr; 45(7):1386-92. PubMed ID: 17188311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations.
    Mongeon D; Blanchet P; Messier J
    Brain Cogn; 2013 Mar; 81(2):271-82. PubMed ID: 23313834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. By carrot or by stick: cognitive reinforcement learning in parkinsonism.
    Frank MJ; Seeberger LC; O'reilly RC
    Science; 2004 Dec; 306(5703):1940-3. PubMed ID: 15528409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of clinical motor variables and medication dosage on working memory in Parkinson's disease.
    Moustafa AA; Bell P; Eissa AM; Hewedi DH
    Brain Cogn; 2013 Jul; 82(2):137-45. PubMed ID: 23660434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study.
    Euteneuer F; Schaefer F; Stuermer R; Boucsein W; Timmermann L; Barbe MT; Ebersbach G; Otto J; Kessler J; Kalbe E
    Neuropsychologia; 2009 Nov; 47(13):2882-90. PubMed ID: 19545579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing rule-based category learning deficits in patients with Parkinson's disease.
    Filoteo JV; Maddox WT; Ing AD; Song DD
    Neuropsychologia; 2007 Jan; 45(2):305-20. PubMed ID: 16978666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.